Methods for treatment of diseases and disorders related to transducin β-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia

• 收藏
• 分享

专利权人:

Beta Cat Pharmaceuticals; LLC

发明人:

Kapil N. Bhalla,Stephen Horrigan

申请号：

US13670377

公开号：

US09238030B2

申请日:

2012.11.06

申请国别(地区):

US

年份:

2016

代理人:

摘要：

Methods for treatment of diseases and disorders related to transducin β-like protein 1 (TBL1) activity, including myeloproliferative neoplasia, chronic myeloid leukemia, and acute myeloid leukemia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/